Combinatorial Immunotherapy Approaches for Patients with Advanced Solid Tumors

A discussion of early-phase clinical trials using intratumoral dendritic cell therapy combined with checkpoint inhibitors or oncolytic virus treatment, highlighting how on-treatment biopsies analyzed with IHC and multiplex immunofluorescence can reveal cellular changes that may serve as surrogate biomarkers.